Trial Profile
A Pilot Study on the Diurnal Variation in PKU Patients With Kuvan.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sapropterin (Primary)
- Indications Phenylketonuria
- Focus Therapeutic Use
- 06 May 2015 New trial record